rituximab-abbs

rituximab-abbs (TRUXIMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

TRUXIMA is a marketed brand name for rituximab-abbs. Check FDA Drugs@FDA for the current US label holder and prescribing information.

rituximab-abbs has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.